The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients.

MLA

Yao-Li Chen, et al. “The Effects of the Location of Cancer Stem Cell Marker CD133 on the Prognosis of Hepatocellular Carcinoma Patients.” BMC Cancer, vol. 17, July 2017, pp. 1–9. EBSCOhost, https://doi.org/10.1186/s12885-017-3460-9.

APA

Yao-Li Chen, Ping-Yi Lin, Ying-Zi Ming, Wei-Chieh Huang, Rong-Fu Chen, Po-Ming Chen, Pei-Yi Chu, Chen, Y.-L., Lin, P.-Y., Ming, Y.-Z., Huang, W.-C., Chen, R.-F., Chen, P.-M., & Chu, P.-Y. (2017). The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients. BMC Cancer, 17, 1–9. https://doi.org/10.1186/s12885-017-3460-9

Chicago

Yao-Li Chen, Ping-Yi Lin, Ying-Zi Ming, Wei-Chieh Huang, Rong-Fu Chen, Po-Ming Chen, Pei-Yi Chu, et al. 2017. “The Effects of the Location of Cancer Stem Cell Marker CD133 on the Prognosis of Hepatocellular Carcinoma Patients.” BMC Cancer 17 (July): 1–9. doi:10.1186/s12885-017-3460-9.